Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-18 | Sarepta Therapeutics, Inc. | Rodino-Klapac Louise
(Head of R&D, CSO) |
F | Common Stock | D | 4558 | $102.89 - $102.89 | $468,972 |
| 2024-09-12 | Sarepta Therapeutics, Inc. | Connelly Deirdre P
(Director) |
A | Common Stock | A | 2842 | $0.00 - $0.00 | $0 |
| 2024-08-16 | Sarepta Therapeutics, Inc. | Chambers Michael ...
(Director) |
P | Common Stock | A | 37038 | $133.07 - $134.66 | $4,955,727 |
| 2024-07-03 | Sarepta Therapeutics, Inc. | BEHRENS M KATHLEEN
(Director) |
M | Common Stock | A | 15000 | $13.90 - $13.90 | $208,500 |
| 2024-06-25 | Sarepta Therapeutics, Inc. | Brown Ryan Edward
(EVP, General Counsel) |
S | Common Stock | D | 38957 | $158.07 - $164.52 | $6,296,026 |
| 2024-06-25 | Sarepta Therapeutics, Inc. | Brown Ryan Edward
(EVP, General Counsel) |
M | Common Stock | A | 23500 | $62.77 - $62.77 | $1,475,095 |
| 2024-06-24 | Sarepta Therapeutics, Inc. | Brown Ryan Edward
(EVP, General Counsel) |
F | Common Stock | D | 2352 | $164.64 - $164.64 | $387,233 |
| 2024-06-24 | Sarepta Therapeutics, Inc. | Rodino-Klapac Louise
(Head of R&D, CSO) |
F | Common Stock | D | 2182 | $164.64 - $164.64 | $359,244 |
| 2024-06-24 | Sarepta Therapeutics, Inc. | Murray Dallan
(Chief Customer Officer) |
F | Common Stock | D | 2352 | $164.64 - $164.64 | $387,233 |
| 2024-06-24 | Sarepta Therapeutics, Inc. | Estepan Ian Michael
(Chief Financial Officer) |
F | Common Stock | D | 2483 | $164.64 - $164.64 | $408,801 |
| 2024-06-24 | Sarepta Therapeutics, Inc. | Arif Bilal
(Chief Tech Ops Officer) |
S | Common Stock | D | 11757 | $162.31 - $167.13 | $1,917,889 |
| 2024-06-24 | Sarepta Therapeutics, Inc. | Arif Bilal
(Chief Tech Ops Officer) |
F | Common Stock | D | 2352 | $164.64 - $164.64 | $387,233 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |